BNP as a biomarker in heart disease.
作者： Olli Vuolteenaho , Minna Ala‐Kopsala , Heikki Ruskoaho
DOI: 10.1016/S0065-2423(05)40001-3
关键词: Internal medicine 、 Natriuretic peptide 、 Myocardial infarction 、 Population 、 Cardiology 、 Heart failure 、 Biomarker (medicine) 、 Fibrosis 、 Natriuresis 、 Heart disease 、 Medicine
摘要: … Subsequently, BNP was found to be a principally cardiac hormone, and in some species there are, in fact, no appreciable quantities of BNP in the brain [10]. Although the …
sci-hub.se 参考文章(155)
KARI YLITALO, PAAVO UUSIMAA, OLLI VUOLTEENAHO, HEIKKI RUSKOAHO, KEIJO PEUHKURINEN, Vasoactive peptide release in relation to hemodynamic and metabolic changes during rapid ventricular pacing. Pacing and Clinical Electrophysiology. ,vol. 22, pp. 1064- 1070 ,(1999) , 10.1111/J.1540-8159.1999.TB00571.X
Paavo Uusimaa, Heikki Tokola, Antti Ylitalo, Olli Vuolteenaho, Heikki Ruskoaho, Juha Risteli, Markku Linnaluoto, Keijo Peuhkurinen, Plasma B-type natriuretic peptide reflects left ventricular hypertrophy and diastolic function in hypertension. International Journal of Cardiology. ,vol. 97, pp. 251- 256 ,(2004) , 10.1016/J.IJCARD.2003.10.015
Wendy Johnson, Torbjørn Omland, Christian Hall, Caroline Lucas, Ole L Myking, Caroline Collins, Marc Pfeffer, Jean-Lucien Rouleau, Lynne W Stevenson, Neurohormonal activation rapidly decreases after intravenous therapy withdiuretics and vasodilators for class IV heart failure Journal of the American College of Cardiology. ,vol. 39, pp. 1623- 1629 ,(2002) , 10.1016/S0735-1097(02)01814-4
Barry J. Maron, Venkatakrishna N. Tholakanahalli, Andrey G. Zenovich, Susan A. Casey, Daniel Duprez, Dorothee M. Aeppli, Jay N. Cohn, Usefulness of B-Type Natriuretic Peptide Assay in the Assessment of Symptomatic State in Hypertrophic Cardiomyopathy Circulation. ,vol. 109, pp. 984- 989 ,(2004) , 10.1161/01.CIR.0000117098.75727.D8
Theresa A McDonagh, Caroline E Morrison, Audrey Lawrence, Ian Ford, Hugh Tunstall-Pedoe, John JV McMurray, Henry J Dargie, Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population. The Lancet. ,vol. 350, pp. 829- 833 ,(1997) , 10.1016/S0140-6736(97)03033-X
Keiji Maekawa, Tetsuji Sudoh, Mitsuru Furusawa, Naoto Minamino, Kenji Kangawa, Hiroaki Ohkubo, Shigetada Nakanishi, Hisayuki Matsuo, Cloning and sequence analysis of cDNA encoding a precursor for porcine brain natriuretic peptide Biochemical and Biophysical Research Communications. ,vol. 157, pp. 410- 416 ,(1988) , 10.1016/0006-291X(89)92269-9
Yoshie Sawada, Masayuki Suda, Hironori Yokoyama, Tsugiyasu Kanda, Tetsuo Sakamaki, Shigeyasu Tanaka, Ryozo Nagai, Shuzo Abe, Toshiyuki Takeuchi, Stretch-induced Hypertrophic Growth of Cardiocytes and Processing of Brain-type Natriuretic Peptide Are Controlled by Proprotein-processing Endoprotease Furin Journal of Biological Chemistry. ,vol. 272, pp. 20545- 20554 ,(1997) , 10.1074/JBC.272.33.20545
R. Pfister, M. Scholz, K. Wielckens, E. Erdmann, C.A. Schneider, Use of NT-proBNP in routine testing and comparison to BNP. European Journal of Heart Failure. ,vol. 6, pp. 289- 293 ,(2004) , 10.1016/J.EJHEART.2003.12.012
A.J. de Bold, H.B. Borenstein, A.T. Veress, H. Sonnenberg, A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats Life Sciences. ,vol. 28, pp. 89- 94 ,(1981) , 10.1016/0024-3205(81)90370-2
E Morita, H Yasue, M Yoshimura, H Ogawa, M Jougasaki, T Matsumura, M Mukoyama, K Nakao, Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction. Circulation. ,vol. 88, pp. 82- 91 ,(1993) , 10.1161/01.CIR.88.1.82